206 related articles for article (PubMed ID: 10485970)
1. Dopamine-transporter occupancy after intravenous doses of cocaine and methylphenidate in mice and humans.
Gatley SJ; Volkow ND; Gifford AN; Fowler JS; Dewey SL; Ding YS; Logan J
Psychopharmacology (Berl); 1999 Sep; 146(1):93-100. PubMed ID: 10485970
[TBL] [Abstract][Full Text] [Related]
2. Chronic methylphenidate alters locomotor activity and dopamine transporters differently from cocaine.
Izenwasser S; Coy AE; Ladenheim B; Loeloff RJ; Cadet JL; French D
Eur J Pharmacol; 1999 Jun; 373(2-3):187-93. PubMed ID: 10414438
[TBL] [Abstract][Full Text] [Related]
3. Blockade of striatal dopamine transporters by intravenous methylphenidate is not sufficient to induce self-reports of "high".
Volkow ND; Wang GJ; Fowler JS; Gatley SJ; Logan J; Ding YS; Dewey SL; Hitzemann R; Gifford AN; Pappas NR
J Pharmacol Exp Ther; 1999 Jan; 288(1):14-20. PubMed ID: 9862747
[TBL] [Abstract][Full Text] [Related]
4. Dopamine transporter occupancies in the human brain induced by therapeutic doses of oral methylphenidate.
Volkow ND; Wang GJ; Fowler JS; Gatley SJ; Logan J; Ding YS; Hitzemann R; Pappas N
Am J Psychiatry; 1998 Oct; 155(10):1325-31. PubMed ID: 9766762
[TBL] [Abstract][Full Text] [Related]
5. Model for estimating dopamine transporter occupancy and subsequent increases in synaptic dopamine using positron emission tomography and carbon-11-labeled cocaine.
Gatley SJ; Volkow ND; Gifford AN; Ding YS; Logan J; Wang GJ
Biochem Pharmacol; 1997 Jan; 53(1):43-52. PubMed ID: 8960062
[TBL] [Abstract][Full Text] [Related]
6. Measuring dopamine transporter occupancy by cocaine in vivo: radiotracer considerations.
Fowler JS; Volkow ND; Logan J; Gatley SJ; Pappas N; King P; Ding YS; Wang GJ
Synapse; 1998 Feb; 28(2):111-6. PubMed ID: 9450511
[TBL] [Abstract][Full Text] [Related]
7. Methylphenidate and cocaine have a similar in vivo potency to block dopamine transporters in the human brain.
Volkow ND; Wang GJ; Fowler JS; Fischman M; Foltin R; Abumrad NN; Gatley SJ; Logan J; Wong C; Gifford A; Ding YS; Hitzemann R; Pappas N
Life Sci; 1999; 65(1):PL7-12. PubMed ID: 10403500
[TBL] [Abstract][Full Text] [Related]
8. Relationship between psychostimulant-induced "high" and dopamine transporter occupancy.
Volkow ND; Wang GJ; Fowler JS; Gatley SJ; Ding YS; Logan J; Dewey SL; Hitzemann R; Lieberman J
Proc Natl Acad Sci U S A; 1996 Sep; 93(19):10388-92. PubMed ID: 8816810
[TBL] [Abstract][Full Text] [Related]
9. Doses of GBR12909 that suppress cocaine self-administration in non-human primates substantially occupy dopamine transporters as measured by [11C] WIN35,428 PET scans.
Villemagne VL; Rothman RB; Yokoi F; Rice KC; Matecka D; Dannals RF; Wong DF
Synapse; 1999 Apr; 32(1):44-50. PubMed ID: 10188637
[TBL] [Abstract][Full Text] [Related]
10. Relationship between subjective effects of cocaine and dopamine transporter occupancy.
Volkow ND; Wang GJ; Fischman MW; Foltin RW; Fowler JS; Abumrad NN; Vitkun S; Logan J; Gatley SJ; Pappas N; Hitzemann R; Shea CE
Nature; 1997 Apr; 386(6627):827-30. PubMed ID: 9126740
[TBL] [Abstract][Full Text] [Related]
11. Binding of d-threo-[11C]methylphenidate to the dopamine transporter in vivo: insensitivity to synaptic dopamine.
Gatley SJ; Ding YS; Volkow ND; Chen R; Sugano Y; Fowler JS
Eur J Pharmacol; 1995 Aug; 281(2):141-9. PubMed ID: 7589201
[TBL] [Abstract][Full Text] [Related]
12. Synergistic interactions between nicotine and cocaine or methylphenidate depend on the dose of dopamine transporter inhibitor.
Gerasimov MR; Franceschi M; Volkow ND; Rice O; Schiffer WK; Dewey SL
Synapse; 2000 Dec; 38(4):432-7. PubMed ID: 11044890
[TBL] [Abstract][Full Text] [Related]
13. Self-administration of cocaine and the cocaine analog RTI-113: relationship to dopamine transporter occupancy determined by PET neuroimaging in rhesus monkeys.
Wilcox KM; Lindsey KP; Votaw JR; Goodman MM; Martarello L; Carroll FI; Howell LL
Synapse; 2002 Jan; 43(1):78-85. PubMed ID: 11746736
[TBL] [Abstract][Full Text] [Related]
14. Dopamine transporter binding without cocaine-like behavioral effects: synthesis and evaluation of benztropine analogs alone and in combination with cocaine in rodents.
Katz JL; Agoston GE; Alling KL; Kline RH; Forster MJ; Woolverton WL; Kopajtic TA; Newman AH
Psychopharmacology (Berl); 2001 Apr; 154(4):362-74. PubMed ID: 11349389
[TBL] [Abstract][Full Text] [Related]
15. Relationship between injection duration, transporter occupancy and reinforcing strength of cocaine.
Woolverton WL; Wang Z
Eur J Pharmacol; 2004 Feb; 486(3):251-7. PubMed ID: 14985046
[TBL] [Abstract][Full Text] [Related]
16. A triple mutation in the second transmembrane domain of mouse dopamine transporter markedly decreases sensitivity to cocaine and methylphenidate.
Chen R; Han DD; Gu HH
J Neurochem; 2005 Jul; 94(2):352-9. PubMed ID: 15998286
[TBL] [Abstract][Full Text] [Related]
17. Binding of bromine-substituted analogs of methylphenidate to monoamine transporters.
Pan D; Gatley SJ; Dewey SL; Chen R; Alexoff DA; Ding YS; Fowler JS
Eur J Pharmacol; 1994 Oct; 264(2):177-82. PubMed ID: 7851480
[TBL] [Abstract][Full Text] [Related]
18. 3'-Chloro-3 alpha-(diphenylmethoxy)tropane but not 4'-chloro-3 alpha-(diphenylmethoxy)tropane produces a cocaine-like behavioral profile.
Kline RH; Izenwasser S; Katz JL; Joseph DB; Bowen WD; Newman AH
J Med Chem; 1997 Mar; 40(6):851-7. PubMed ID: 9083473
[TBL] [Abstract][Full Text] [Related]
19. Effects of methylphenidate analogues on phenethylamine substrates for the striatal dopamine transporter: potential as amphetamine antagonists?
Wayment HK; Deutsch H; Schweri MM; Schenk JO
J Neurochem; 1999 Mar; 72(3):1266-74. PubMed ID: 10037500
[TBL] [Abstract][Full Text] [Related]
20. Evidence that pure uptake inhibitors including cocaine interact slowly with the dopamine neuronal carrier.
Héron C; Costentin J; Bonnet JJ
Eur J Pharmacol; 1994 Nov; 264(3):391-8. PubMed ID: 7698180
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
